Daejeon, South Korea

Jong Hee Lee

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong Hee Lee. Retrieved from https://idiyas.com/inventor/jong-hee-lee-v95ssdq6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jong Hee Lee

Introduction

Jong Hee Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience and biotechnology. His work focuses on genetic mutations and their implications in various biological models.

Latest Patents

Jong Hee Lee holds a patent titled "Dwarfism Animal Model Having IGF-1 Genetic Mutation and Method for Producing Same." This innovative patent addresses important aspects of genetic research and animal modeling.

Career Highlights

He is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work has garnered attention for its potential applications in understanding genetic disorders.

Collaborations

Jong Hee Lee collaborates with notable colleagues, including Yeung Bae Jin and Kyung Seob Lim. Their combined expertise enhances the research output and innovation at their institution.

Conclusion

Jong Hee Lee's contributions to the field of biotechnology through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…